185 related articles for article (PubMed ID: 27340176)
1. INO80 governs superenhancer-mediated oncogenic transcription and tumor growth in melanoma.
Zhou B; Wang L; Zhang S; Bennett BD; He F; Zhang Y; Xiong C; Han L; Diao L; Li P; Fargo DC; Cox AD; Hu G
Genes Dev; 2016 Jun; 30(12):1440-53. PubMed ID: 27340176
[TBL] [Abstract][Full Text] [Related]
2. INO80 is required for oncogenic transcription and tumor growth in non-small cell lung cancer.
Zhang S; Zhou B; Wang L; Li P; Bennett BD; Snyder R; Garantziotis S; Fargo DC; Cox AD; Chen L; Hu G
Oncogene; 2017 Mar; 36(10):1430-1439. PubMed ID: 27641337
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells.
Laurette P; Strub T; Koludrovic D; Keime C; Le Gras S; Seberg H; Van Otterloo E; Imrichova H; Siddaway R; Aerts S; Cornell RA; Mengus G; Davidson I
Elife; 2015 Mar; 4():. PubMed ID: 25803486
[TBL] [Abstract][Full Text] [Related]
4. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
Vachtenheim J; Ondrusová L; Borovanský J
Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
[TBL] [Abstract][Full Text] [Related]
5. Disruption of cardiac Med1 inhibits RNA polymerase II promoter occupancy and promotes chromatin remodeling.
Hall DD; Spitler KM; Grueter CE
Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H314-H325. PubMed ID: 30461303
[TBL] [Abstract][Full Text] [Related]
6. Human INO80/YY1 chromatin remodeling complex transcriptionally regulates the BRCA2- and CDKN1A-interacting protein (BCCIP) in cells.
Su J; Sui Y; Ding J; Li F; Shen S; Yang Y; Lu Z; Wang F; Cao L; Liu X; Jin J; Cai Y
Protein Cell; 2016 Oct; 7(10):749-760. PubMed ID: 27535137
[TBL] [Abstract][Full Text] [Related]
7. The INO80 complex activates the transcription of S-phase genes in a cell cycle-regulated manner.
Knezevic I; González-Medina A; Gaspa L; Hidalgo E; Ayté J
FEBS J; 2018 Oct; 285(20):3870-3881. PubMed ID: 30134042
[TBL] [Abstract][Full Text] [Related]
8. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.
Du J; Miller AJ; Widlund HR; Horstmann MA; Ramaswamy S; Fisher DE
Am J Pathol; 2003 Jul; 163(1):333-43. PubMed ID: 12819038
[TBL] [Abstract][Full Text] [Related]
9. Ino80 promotes cervical cancer tumorigenesis by activating Nanog expression.
Hu J; Liu J; Chen A; Lyu J; Ai G; Zeng Q; Sun Y; Chen C; Wang J; Qiu J; Wu Y; Cheng J; Shi X; Song L
Oncotarget; 2016 Nov; 7(44):72250-72262. PubMed ID: 27750218
[TBL] [Abstract][Full Text] [Related]
10. Ino80 chromatin remodeling complex promotes recovery of stalled replication forks.
Shimada K; Oma Y; Schleker T; Kugou K; Ohta K; Harata M; Gasser SM
Curr Biol; 2008 Apr; 18(8):566-75. PubMed ID: 18406137
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
12. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic suppression of PHLPP1 in human melanoma.
Dong L; Jin L; Tseng HY; Wang CY; Wilmott JS; Yosufi B; Yan XG; Jiang CC; Scolyer RA; Zhang XD; Guo ST
Oncogene; 2014 Sep; 33(39):4756-66. PubMed ID: 24121273
[TBL] [Abstract][Full Text] [Related]
14. Promoter-enhancer looping at the PPARγ2 locus during adipogenic differentiation requires the Prmt5 methyltransferase.
LeBlanc SE; Wu Q; Lamba P; Sif S; Imbalzano AN
Nucleic Acids Res; 2016 Jun; 44(11):5133-47. PubMed ID: 26935580
[TBL] [Abstract][Full Text] [Related]
15. [Epigenetic regulation of gene expression in malignant melanoma].
Laurette P; Koludrovic D; Coassolo S; Davidson I
Biol Aujourdhui; 2016; 210(4):283-295. PubMed ID: 28327285
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms.
Jia Q; Chen S; Tan Y; Li Y; Tang F
Exp Mol Med; 2020 May; 52(5):713-723. PubMed ID: 32382065
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
[TBL] [Abstract][Full Text] [Related]
18. Differential Expression of SWI/SNF Chromatin Remodeler Subunits Brahma and Brahma-Related Gene During Drug-Induced Liver Injury and Regeneration in Mouse Model.
Sinha S; Verma S; Chaturvedi MM
DNA Cell Biol; 2016 Aug; 35(8):373-84. PubMed ID: 27097303
[TBL] [Abstract][Full Text] [Related]
19. BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance.
Tasdemir N; Banito A; Roe JS; Alonso-Curbelo D; Camiolo M; Tschaharganeh DF; Huang CH; Aksoy O; Bolden JE; Chen CC; Fennell M; Thapar V; Chicas A; Vakoc CR; Lowe SW
Cancer Discov; 2016 Jun; 6(6):612-29. PubMed ID: 27099234
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death.
Ye Y; Xiao Y; Wang W; Wang Q; Yearsley K; Wani AA; Yan Q; Gao JX; Shetuni BS; Barsky SH
Mol Cancer Res; 2009 Dec; 7(12):1984-99. PubMed ID: 19996304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
